Liss M - Search Results

1

Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials.

Gelfond JA, Hernandez B, Goros M, Ibrahim JG, Chen MH, Sun W, Leach RJ, Kattan MW, Thompson IM, Ankerst DP, Liss M. Gelfond JA, et al. Among authors: liss m. BMC Urol. 2022 Mar 26;22(1):45. doi: 10.1186/s12894-022-00986-w. BMC Urol. 2022. PMID: 35351104 Free PMC article.

2

Robot-assisted radical prostatectomy: 5-year oncological and biochemical outcomes.

Liss MA, Lusch A, Morales B, Beheshti N, Skarecky D, Narula N, Osann K, Ahlering TE. Liss MA, et al. J Urol. 2012 Dec;188(6):2205-10. doi: 10.1016/j.juro.2012.08.009. Epub 2012 Oct 22. J Urol. 2012. PMID: 23083657 Review.

3

Impact of family history on prostate cancer mortality in white men undergoing prostate specific antigen based screening.

Liss MA, Chen H, Hemal S, Krane S, Kane CJ, Xu J, Kader AK. Liss MA, et al. J Urol. 2015 Jan;193(1):75-9. doi: 10.1016/j.juro.2014.07.085. Epub 2014 Jul 24. J Urol. 2015. PMID: 25066872

4

Impact of prostate-specific antigen on a baseline prostate cancer risk assessment including genetic risk.

Kader AK, Liss MA, Trottier G, Kim ST, Sun J, Zheng SL, Chadwick K, Lockwood G, Xu J, Fleshner NE. Kader AK, et al. Urology. 2015 Jan;85(1):165-70. doi: 10.1016/j.urology.2014.07.081. Urology. 2015. PMID: 25530379 Free PMC article.

5

Reply: To PMID 25530379.

Kader AK, Liss MA, Xu J, Fleshner NE. Kader AK, et al. Urology. 2015 Jan;85(1):171. doi: 10.1016/j.urology.2014.07.083. Urology. 2015. PMID: 25530381 No abstract available.

6

Prostate genetic score (PGS-33) is independently associated with risk of prostate cancer in the PLCO trial.

Liss MA, Xu J, Chen H, Kader AK. Liss MA, et al. Prostate. 2015 Sep;75(12):1322-8. doi: 10.1002/pros.23012. Epub 2015 May 15. Prostate. 2015. PMID: 25982801 Clinical Trial.

7

Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening Study.

Morales EE, Grill S, Svatek RS, Kaushik D, Thompson IM Jr, Ankerst DP, Liss MA. Morales EE, et al. Among authors: liss ma. Eur Urol. 2016 Mar;69(3):407-10. doi: 10.1016/j.eururo.2015.08.029. Epub 2015 Aug 28. Eur Urol. 2016. PMID: 26320383

8

A case control study of sarcosine as an early prostate cancer detection biomarker.

Ankerst DP, Liss M, Zapata D, Hoefler J, Thompson IM, Leach RJ. Ankerst DP, et al. Among authors: liss m. BMC Urol. 2015 Oct 1;15:99. doi: 10.1186/s12894-015-0095-5. BMC Urol. 2015. PMID: 26429735 Free PMC article.

9

A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable moment.

Liss MA, Schenk JM, Faino AV, Newcomb LF, Boyer H, Brooks JD, Carroll PR, Dash A, Fabrizio MD, Gleave ME, Nelson PS, Neuhouser ML, Wei JT, Zheng Y, Wright JL, Lin DW, Thompson IM. Liss MA, et al. Prostate Cancer Prostatic Dis. 2016 Dec;19(4):390-394. doi: 10.1038/pcan.2016.28. Epub 2016 Jul 19. Prostate Cancer Prostatic Dis. 2016. PMID: 27431498 Free PMC article.

10

TGF-β signal rewiring sustains epithelial-mesenchymal transition of circulating tumor cells in prostate cancer xenograft hosts.

Huang G, Osmulski PA, Bouamar H, Mahalingam D, Lin CL, Liss MA, Kumar AP, Chen CL, Thompson IM, Sun LZ, Gaczynska ME, Huang TH. Huang G, et al. Among authors: liss ma. Oncotarget. 2016 Nov 22;7(47):77124-77137. doi: 10.18632/oncotarget.12808. Oncotarget. 2016. PMID: 27780930 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

305 results

Search Page